TIME COURSE OF CHANGES IN THE LEVEL OF C-TERMINAL TELOPEPTIDES DURING THERAPY IN PATIENTS WITH OSTEOARTHRITIS
Issue:
5
Year:
2016
The level of C-terminal telopeptides arising from collagen type II degradation during 3-month therapy using chondroitin sulfate (Structum), its combination with glucosamine hydrochloride (Artra) and Zeel T was estimated in patients with osteoarthritis. Better values were observed in gonarthrosis, particularly when Artra was used at the early stages of the disease; worse values were seen in Stage III osteoarthritis and its duration > 10 years.
Keywords:
osteoarthritis
chondroitin sulfate
glucosamine hydrochloride
Zeel T
C-terminal telopeptides arising from collagen type II
References:
- Alekseeva L.I., Chichasova N.V., Mendel' O.I. Ratsional'nyj vybor bazisnoj terapii pri osteoartroze. Rezul'taty otkrytogo randomizirovan-nogo mnogotsentrovogo issledovanija preparata ARTRA® v Rossii // RMZh. – 2005; 13 (24): 1637–41.
- Karateev A.E. Gastroduodenal'naja bezopasnost' selektivnyh ingibito rov tsiklooksigenazy-2: proverka praktikoj // Ter. arh. – 2005; 5: 69–72.
- Karateev A.E., Alekseeva L.I., Bratygina E.A. Otsenka chastoty razvitija pobochnyh effektov pri dlitel'nom primenenii nimesulida v real'noj klinicheskoj praktike // RMZh. – 2009; 17 (21): 1466–72.
- Majko O.Ju. Kliniko-ekonomicheskie aspekty primenenija nestero idnyh protivovospalitel'nyh i modifitsirujuschih strukturu hrjascha sredstv pri osteoartroze. Avtoref. dis. … d-ra med. nauk. Orenburg, 2008; 43 s.
- Nasonova V.A., Alekseeva L.I., Arhangel'skaja G.S. i dr. Itogi mnogo tsentrovogo klinicheskogo issledovanija preparata struktum v Rossii // Ter. arh. – 2001; 11: 84–7.
- Nasonova V.A. Osteoartroz: problema polimorbidnosti // Consilium 6. Medicum. – 2009; 11 (2): 234–45.
- Shtresser V., Vajzer M. Gomeopaticheskoe lechenie gonartroza: rezul'taty dvojnogo slepogo issledovanija // Biol. meditsina. – 2001; 2: 21–6.
- Erdes Sh.F., Folomeeva O.M. Revmaticheskie zabolevanija i invalid nost' vzroslogo naselenija Rossijskoj Federatsii // Nauchno-prakticheskaja revmatol. – 2007; 4: 4–9.
- Christgan S., Henrotin Y., Tanko L. Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate // Clin. Exp. Rheumatol. – 2004; 22 (1): 36–42.
- Ishijima M., Watari T., Naito K. et al. Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis // Arthritis Research & Therapy. – 2011; 13 (1): 2.
- Jung M. Elevated urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis // Pathobiology. – 2004; 71 (2): 70–6.
- Hochberg M. Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration // Osteoarthritis Cartilage. – 2010; 18 (1): 28–31.
- Garnero P., Charni N., Juillet F. et al. Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis // Ann. Rheum. Dis. – 2006; 65: 1639–44.
- Gineyts E., Mo J., Ko A. et. al. Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis // Ann. Rheum. Dis. – 2004; 63: 857–61.
- Kahan A., Uebelhart D. et al. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial // Arthr. Rheum. – 2009; 60: 524–33.
- Manicourt D., Bevilacqua M., Righini V. et al. Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and -13 in patients with flare-up of osteoarthritis // Drugs R.D. – 2005; 6: 261–71.
- Mazzuca S., Brandt K., Eyre D. et al. Urinary levels of type II collagen c-telopeptide crosslinks are unrelated to joint space narrowing in patients with knee osteoarthritis // Ann. Rheum. Dis. – 2006; 65: 1055–9.
- Marrona U., Weiser M., Klein P. Orale Behandlung der Gonarthrose mit Zeel compositum // Orthop. Praxis. – 2000; 5: 285–91
- Oestergaard S., Chouinard L., Doyle N. et al. Early elevation in circulating levels of C-telopeptides of type II collagen predicts structural damage in articular cartilage in the rodent model of collagen-induced arthritis // Arthr. Rheum. – 2006; 54: 2886–90
- Rozendaal R., Uitterlinden E. et al. Glucosamine sulphate effects on joint space narrowing, pain and function in patients with hip osteoarthritis; subgroup analyses of a randomized controlled trial // Osteoarthritis Cartilage. – 2009; 17: 427–32.
- Reijman M., Hazes J., Bierma-Zeinstra S. A new marker for osteoarthritis: 21. cross-sectional and longitudinal approach // Arthr. Rheum. – 2004; 50; 2471–8.
- Sharif M., Kirwan J., Charni N. et al. A 5-yr longitudinal study of type IIA 22. collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis-association with disease progression // Rheumatology. – 2007; 46: 938–43.
- Zhang W., Nuki G., Moskowitz R. et al. OARSI recommendations for the 23. management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009 // Osteoarthritis Cartilage. – 2010; 18: 476–99.